Why is Piramal Pharma falling/rising?

As of 15-Jul, Piramal Pharma Ltd's stock price is currently at 216.35, reflecting an increase of 8.5, or 4.09%. The stock has been on an upward trend, gaining for the last three days and achieving a return of 7.8% over the past month. Today's performance indicates that it has outperformed its sector by 2.84%. The stock also reached an intraday high of Rs 217.85, and there has been a significant increase in investor participation, with delivery volume rising by 344.76% compared to the five-day average. Positive factors contributing to this rise include strong operating profit growth and high institutional holdings, which suggest confidence in the company's fundamentals. However, the company faces challenges with a high Debt to EBITDA ratio and low Return on Equity, which could temper long-term investor sentiment.
In the broader market context, Piramal Pharma's short-term performance has significantly outpaced the benchmark Sensex, which has declined by 1.36% over the past week while the stock has risen by 7.48%. This contrast highlights the stock's resilience and market-beating performance, particularly with a 42.24% return over the past year compared to the Sensex's modest gain of 2.36%. Despite the positive momentum, the company's high debt levels and low profitability metrics may raise concerns among investors, potentially impacting future stock performance.